Cepheid Logs Strong Q4, FY2011 Growth; Cites Both Commercial, Developing-World GeneXpert Sales
February 02, 2012
Cepheid Logs Strong Q4, FY2011 Growth; Cites Both Commercial, Developing-World GeneXpert Sales
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Unitaid Provides $30M to Reduce Cost, Increase Uptake of Cepheid TB Test in Developing World
June 14, 2012 / PCR Insider - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - Dx Focus: PEPFAR Funding Drives Cepheid TB Test Uptake; Curetis Starts US Trials for MDx System
December 6, 2012 / PCR Insider - UNC Team Wins NIH Grant to Study Treatment Outcomes of TB Patients Diagnosed with Cepheid Test
April 12, 2012 / PCR Insider - FIND Study Shows Cepheid TB Test Performs Well in Remote Labs, Reduces Time to Treatment
April 21, 2011 / PCR Insider